Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, September 03, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
908 Devices Introduces World’s First Handheld Mass Spectrometer
Tuesday, March 11, 2014
M908 uses patented high-pressure mass spectrometry to enhance detection and identification capabilities for first responders.

New HPLC Column Separates Challenging Glycan Isomers
Wednesday, March 05, 2014
Company will showcase the GlycanPac AXR-1 column at Pittcon 2014.

AB Sciex Delivers Breakthrough for Therapeutic Biologics with Innovative CESI-MS Solution
Wednesday, March 05, 2014
First robust, commercially available ultra-low flow electrospray ionization instrument links CE technology to mass spectrometry for groundbreaking results.

Waters Marks Ten Years of ACQUITY UPLC at Pittcon
Monday, March 03, 2014
The Company looks to the future with ACQUITY QDa and ionkey/MS Drive LC/MS Convergence with Mass Detection for Chromatographers and Separations for Spectrometrists Respectively.

Hiden Gas Analyzers at Pittcon 2014
Friday, February 28, 2014
Pittcon Conference & Expo 2014 to be held at McCormick Place, USA, March 2 - 6, 2014.

Agilent to Introduce Platforms for Spectroscopy Solutions in Vietnam
Friday, February 28, 2014
Total Agilent experience 2014 to feature top industry speakers, technologies.

Agilent Introduces 1260 Infinity Multi-Detector Bio-SEC Solution
Friday, February 28, 2014
Liquid chromatography solution provides unmatched analytical capacity for large-molecule biotherapeutic development.

Polymeric Solid Phase Extraction Cartridges for Organic Contaminants
Saturday, February 22, 2014
Thermo Scientific™ Dionex™ Polymeric SolEx™ SPE Cartridges for the extraction of organic contaminants.

New Ion Source Technology for GC-MS Launched at Pittcon 2014
Saturday, February 22, 2014
New Select-eV technology showcased at Pittcon 2014 from March 2-6 in Chicago.

<< 5 6 7 8 9 10 11 >>
Showing Results 71 - 80 of 1094
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv